Xcout Intel
Cidara Therapeutics, Inc.
Cidara Therapeutics, Inc. is a biotechnology company focused on developing late-phase antiviral and immunotherapy agents, with operations based in San Diego, California and Rahway, New Jersey.
Subscribe to see Cidara Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Cidara Therapeutics, Inc. at a glance
Cidara Therapeutics, Inc. is a biopharmaceuticals company headquartered in United States. It has raised at least $312.8M across the 5 funding rounds on record. Its most recent funding round raised $240M in April 2024. Xcout tracks 1 named person at Cidara Therapeutics, Inc., including Rob Davis (chairman of the board and chief executive officer).
Cidara Therapeutics, Inc. leadership
- Rob Davischairman of the board and chief executive officer
Cidara Therapeutics, Inc. funding rounds
At least $312.8M raised across the 5 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $240M | — | |
| SEC Form D filing | $9M | — | |
| SEC Form D filing | $1.6M | — | |
| SEC Form D filing | $20.2M | — | |
| SEC Form D filing | $42M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Cidara Therapeutics, Inc. competitors
A few of Cidara Therapeutics, Inc.'s closest competitors — see the full list of competitors and alternatives →
Amplyx Pharmaceuticals, Inc. was a San Diego-based clinical-stage biotechnology company developing treatments for serious and potentially life-threatening fungal infections. Its lead investigational drug, fosmanogepix, was acquired by Pfizer when Pfizer acquired Amplyx in 2021 and is being developed for patients with invasive fungal diseases.
Chimerix, Inc. is a biopharmaceutical company that develops medicines for oncology and other critical illnesses, serving US-based healthcare audiences and patients.
ChemoCentryx, Inc. is a biopharmaceutical company with its corporate headquarters and principal place of business located in California.
Achaogen Inc was a biopharmaceutical company headquartered in South San Francisco, California. The company focused on discovering, developing, and commercializing novel antibacterial treatments.
F2G is a biotechnology research company headquartered in the UK with subsidiaries in the US and Austria. The company specializes in developing novel therapeutics and antifungal treatments for rare fungal infections.
Get Cidara Therapeutics, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Cidara Therapeutics, Inc. in Xcout Intel
- 1 named person with titles, LinkedIn and board committees
- 5 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access